Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Fecal Microbiota Transplantation × Clear all
NCT02770326 2025-04-08

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Memorial Sloan Kettering Cancer Center

Phase NA Completed
10 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT03341143 2024-10-30

Fecal Microbiota Transplant (FMT) in Melanoma Patients

University of Pittsburgh

Phase 2 Completed
20 enrolled 19 charts
Dermatologic

Melanoma

NCT03678493 2024-05-16

A Study of FMT in Patients With AML Allo HSCT in Recipients

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
100 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡